Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Recordati: dividend per share 2012-2017

Dividend per share (EPS) of the Italian pharmaceutical company Recordati from 2012 to 2017 (in euros)

by Statista Research Department, last edited Jan 16, 2019
Recordati: dividend per share 2012-2017 This statistic displays the dividend per share of the Italian pharmaceutical company Recordati, from 2012 to 2017. Over the period considered, the dividend per share of Recordati steadily increased, peaking at 0.85 euros per share in 2017.
Show more

Dividend per share (EPS) of the Italian pharmaceutical company Recordati from 2012 to 2017 (in euros)

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.